Elena Liew
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Proposed Modifications to Prognostic Classification of AML Patients Treated With Intensive Chemotherapy Based on Recent Real-World Data.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 29, 2025
A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia With Azacitidine Plus Venetoclax.
Journal: Clinical lymphoma, myeloma & leukemia
Published: December 27, 2024
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Journal: British journal of haematology
Published: April 17, 2023
Changing frontline AML treatment patterns from 2013 to 2022.
Journal: Leukemia research
Published: February 19, 2023
BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
Journal: British journal of haematology
Published: June 01, 2021
Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI.
Journal: Leukemia research
Published: April 22, 2021
Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
Journal: British journal of haematology
Published: January 21, 2021
An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia.
Journal: American journal of hematology
Published: August 19, 2020
The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease.
Journal: European journal of haematology
Published: March 29, 2016
Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid Leukemia.
Journal: Leukemia research
Published: February 24, 2016
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 28, 2015
Last Updated: 09/26/2026